Nobilis Health Corp. Launches Bundled-Payment and Health Technology Initiative With Formation of Concertis, LLC

HOUSTON, TX--(Marketwired - May 02, 2016) - Nobilis Health Corp. (NYSE MKT: HLTH) (TSX: NHC) ("Nobilis" or the "Company") announced today that it has launched Concertis, LLC ("Concertis"), a 100% Nobilis-owned entity. Concertis is a comprehensive technology platform that will develop new payment and delivery methodologies to enhance value for patients, payers, and providers across the continuum of care. Marissa W. Arreola, a former health law partner at the firm Baker Donelson, will lead this division as its president. "Concertis' proprietary technology platform coupled with its commitment to developing unique bundled payment networks will result in high quality health care without the financial and administrative burdens of traditional fee-for service model," said Ms. Arreola.

Clinical Integration Network Formation and Administration
Concertis will align independent physicians and health care facilities with payers to offer alternatives to the traditional fee-for-service model. The company will negotiate with payers (insurance companies and self-insured employers) to combine reimbursement for multiple providers and facilities into a single comprehensive bundled payment that covers all of the services involved in a patient's episode of care. This clinical integration strategy will result in improved patient outcomes, integrated care, expense savings, and enhanced revenue. The bundled payment component of this clinical integration product will also provide a warranty for surgical services, alleviating financial risk for payers and patients.

Population Health Management
Concertis will aggregate patient data culled from multiple platforms and analyze it to manage specific diseases and episodes of care. This powerful data tool will enable health care providers, facilities, and payers to improve clinical and financial outcomes through implementation of clinical best practices. Concertis will not only track data but will also take action by engaging patients in their treatment and recovery plans. Concertis' care navigation team will work with patients until 30-60 days following surgery, and all complications and readmissions occurring during the warranty period will be covered within the initial bundled payment, alleviating financial risk for payers and patients.

Care Coordination
Concertis' care navigators will serve as concierges to patients, guiding them through the entire episode of care to provide a personalized healthcare experience that will minimize costly post-surgical complications.

"Bundled payments and performance based healthcare are going to be the driving force of healthcare as the industry moves to more efficient and cost effective delivery of healthcare services," said Harry Fleming, Nobilis' CEO. "Nobilis is positioning itself to be at the forefront of this movement by investing in the talent and technology today. We have acquired some of the top talent in Texas in both healthcare, with Ms. Arreola, and technology, with Lee McMillian, Ph.D., Nobilis' Vice President of IT. These two executives have led the development of these types of programs at multi-billion dollar enterprises. As we roll out the Concertis model we expect it will contribute a significant number of patients to our network of physicians to supplement our proven technology based marketing model," continued Fleming.

About Nobilis Health Corp.
Nobilis (www.NobilisHealth.com) is a full-service healthcare development and management company which currently owns or manages four surgical hospitals and five ASCs, partners with an additional thirty-three facilities throughout the country, and markets six independent brands. Deploying a unique patient acquisition strategy driven by direct-to-consumer marketing, Nobilis is focused on a specified set of procedures that are performed at our centers by local physicians.

Forward-Looking Statements
This press release contain certain forward-looking statements within the meaning of Canadian and United States securities laws, including the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as "may," "believe," "will," "expect," "project," "estimate," "anticipate," "plan" or "continue." These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance and achievements to differ materially from those anticipated, include, but are not limited to the risk that we may face challenges managing our new Marketing Segment and may not realize anticipated benefits; our ability to successfully maintain effective internal controls over financial reporting; our ability to implement our business strategy, manage the growth in our business, and integrate acquired businesses; the risk of litigation and investigations, and liability claims for damages and other expenses not covered by insurance; the risk that payments from third-party payers, including government healthcare programs, may decrease or not increase as costs increase; adverse developments affecting the medical practices of our physician limited partners; our ability to maintain favorable relations with our physician limited partners; our ability to grow revenues by increasing case and procedure volume while maintaining profitability at the Nobilis Facilities; failure to timely or accurately bill for services; our ability to compete for physician partners, patients and strategic relationships; the risk of changes in patient volume and patient mix; the risk that laws and regulations that regulate payments for medical services made by government healthcare programs could cause our revenues to decrease; the risk that contracts are cancelled or not renewed or that we are not able to enter into additional contracts under terms that are acceptable to us; and the risk of potential decreases in our reimbursement rates. The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect us in an adverse manner.

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. Subject to an mandatory requirements of applicable law, we disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, filed on March 15, 2016, as updated by other filings with the Securities and Exchange Commission.